Literature DB >> 19800464

Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging.

Srila Samphao1, Amanda J Wheeler, Elizabeth Rafferty, James S Michaelson, Michelle C Specht, Michele A Gadd, Kevin S Hughes, Barbara L Smith.   

Abstract

BACKGROUND: The impact of newer breast imaging technologies and genetic testing on the detection of breast cancer in women age 40 and younger remains unknown.
METHODS: A records review identified 628 women age 40 and younger diagnosed with breast cancer from 1996 to 2008. Patient and tumor characteristics, means of diagnosis, imaging results, and genetic testing were examined.
RESULTS: Tumors were first detected by self-examination in 71%, with a median invasive tumor size of 2.0 cm. Imaging performed at or after diagnosis visualized most tumors; mammography visualized 86%, magnetic resonance imaging (MRI) visualized 96%, and mammography plus MRI visualized more than 98% of tumors. For 81% of patients, the mammogram at diagnosis was their first mammogram. Although 50% had a family history of breast or ovarian cancer, few underwent genetic testing before their cancer diagnosis; 61 of 247 (25%) ultimately tested had a BRCA mutation.
CONCLUSIONS: Better use of genetic testing, mammography, and MRI could improve breast cancer detection in young women.

Entities:  

Mesh:

Year:  2009        PMID: 19800464     DOI: 10.1016/j.amjsurg.2009.06.010

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  16 in total

1.  Variations in the Referral Pattern for Genetic Counseling of Patients with Early-Onset Breast Cancer: A Population-Based Study in Southern Sweden.

Authors:  Annelie Augustinsson; Carolina Ellberg; Ulf Kristoffersson; Håkan Olsson; Hans Ehrencrona
Journal:  Public Health Genomics       Date:  2020-07-08       Impact factor: 2.000

2.  Providers' perceptions and practices regarding BRCA1/2 genetic counseling and testing in African American women.

Authors:  Kristi D Graves; Juleen Christopher; Toni Michelle Harrison; Beth N Peshkin; Claudine Isaacs; Vanessa B Sheppard
Journal:  J Genet Couns       Date:  2011-08-06       Impact factor: 2.537

3.  Breast cancer and screening in American Indian and Alaska Native women.

Authors:  Marilyn A Roubidoux
Journal:  J Cancer Educ       Date:  2012-04       Impact factor: 2.037

4.  Intracystic papillary carcinoma of the breast in a 21-year old premenopausal Nigerian woman: a case report.

Authors:  Ivy N Umanah; Akpan S Okpongette
Journal:  Rare Tumors       Date:  2009-12-28

5.  Medical mistrust influences black women's level of engagement in BRCA 1/2 genetic counseling and testing.

Authors:  Vanessa B Sheppard; Darren Mays; Thomas LaVeist; Kenneth P Tercyak
Journal:  J Natl Med Assoc       Date:  2013       Impact factor: 1.798

6.  Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study.

Authors:  Anne Marie McCarthy; Mirar Bristol; Tracey Fredricks; Lache Wilkins; Irene Roelfsema; Kaijun Liao; Judy A Shea; Peter Groeneveld; Susan M Domchek; Katrina Armstrong
Journal:  Cancer       Date:  2013-07-16       Impact factor: 6.860

7.  Hormonal therapies in young breast cancer patients: when, what and for how long?

Authors:  Alexandre Christinat; Simona Di Lascio; Olivia Pagani
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

8.  Breast cancer in the young: role of the geneticist.

Authors:  Ashley H Woodson; Jessica L Profato; Kimberly I Muse; Jennifer K Litton
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

9.  Management of the asymptomatic BRCA mutation carrier.

Authors:  Paige Teller; Rita K Kramer
Journal:  Appl Clin Genet       Date:  2010-11-24

Review 10.  Triple negative breast cancer: looking for the missing link between biology and treatments.

Authors:  Giuseppe Palma; Giuseppe Frasci; Andrea Chirico; Emanuela Esposito; Claudio Siani; Carmela Saturnino; Claudio Arra; Gennaro Ciliberto; Antonio Giordano; Massimiliano D'Aiuto
Journal:  Oncotarget       Date:  2015-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.